PicoCELA Inc. (PCLA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Feb 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PCLA SEC filings page.
PicoCELA Inc. (PCLA) reported $3.7M in revenue for fiscal year 2025, down 32.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of PicoCELA Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
PicoCELA Inc. held $3.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $3.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and PicoCELA Inc. scores 35/100 among other emerging companies.
PicoCELA Inc. had 1M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and PicoCELA Inc. scores 91/100 among other emerging companies.
PicoCELA Inc. spent $177K on research and development in fiscal year 2025, which was 2.3% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and PicoCELA Inc. scores 14/100 among other emerging companies.
PicoCELA Inc. reported revenue of $3.7M in fiscal year 2025, against $5.5M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and PicoCELA Inc. scores 43/100 among other emerging companies.
PicoCELA Inc.'s operations used $3.7M of cash in fiscal year 2025, against $1.7M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and PicoCELA Inc. scores 61/100 among other emerging companies.
PicoCELA Inc.'s cash, cash equivalents and investments came to $3.6M at the end of fiscal year 2025, against $4.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and PicoCELA Inc. scores 57/100 among other emerging companies.
PicoCELA Inc. scores 3.74, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $56.5M against total liabilities of $4.2M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
PicoCELA Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.
PicoCELA Inc. reported a net loss of $4.2M while operations used $3.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
PicoCELA Inc. reported an operating loss of $4.1M against $118K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
PicoCELA Inc. generated $3.7M in revenue in fiscal year 2025. This represents a decrease of 32.8% from the prior year.
PicoCELA Inc.'s EBITDA was -$3.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.
PicoCELA Inc. reported a net loss of $4.2M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Cash & Balance Sheet
PicoCELA Inc. recorded an outflow of $3.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
PicoCELA Inc. held $3.6M in cash against $71K in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
PicoCELA Inc.'s ROE was -133.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.0 percentage points from the prior year.
Not reported for fiscal year 2025.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
PicoCELA Inc. invested $177K in research and development in fiscal year 2025. This represents a decrease of 48.2% from the prior year.
PicoCELA Inc. invested $192K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 45.8% from the prior year.
Not reported for fiscal year 2025.
PCLA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|
| Revenue | $3.7M-32.8% | $5.5M+46.2% | $3.7M-20.6% | $4.7M |
| R&D Expenses | $177K-48.2% | $342K-32.4% | $506K+80.3% | $281K |
| SG&A Expenses | $6.0M-0.8% | $6.1M+1.1% | $6.0M+91.7% | $3.1M |
| Operating Income | -$4.1Mn/m | -$3.1Mn/m | -$4.2Mn/m | -$112K |
| EBITDA | -$3.9Mn/m | -$3.0Mn/m | -$4.1Mn/m | -$55K |
| Interest Expense | $118K-45.7% | $217K | N/A | N/A |
| Net Income | -$4.2Mn/m | -$3.4Mn/m | -$4.2Mn/m | -$36K |
| EPS (Basic) | -$4.62 | -$9.32 | -$17.97 | -$0.01 |
| EPS (Diluted) | -$4.62 | -$9.32 | -$17.97 | -$0.01 |
| Diluted Shares (Avg) | 916,550 | 359,604 | 236,094 | 7M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Income Tax.
PCLA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|
| Total Assets | $7.3M-14.8% | $8.6M+12.1% | $7.7M | N/A |
| Current Assets | $6.7M+1.4% | $6.6M-2.2% | $6.8M | N/A |
| Cash & Equivalents | $3.6M+13.4% | $3.2M+11.3% | $2.9M | N/A |
| Short-Term Investments | $0n/m | $0n/m | $0 | N/A |
| Inventory | $1.8M+23.8% | $1.4M+17.2% | $1.2M | N/A |
| Accounts Receivable | $327K-78.5% | $1.5M+7.6% | $1.4M-22.5% | $1.8M |
| Long-Term Investments | $0n/m | $0n/m | $0 | N/A |
| Total Liabilities | $4.2M-32.1% | $6.1M+102.5% | $3.0M | N/A |
| Current Liabilities | $3.1M+3.5% | $3.0M+23.8% | $2.5M | N/A |
| Non-Current Liabilities | $1.0M-66.9% | $3.1M+436.3% | $579K | N/A |
| Long-Term Debt | $71K-64.3% | $197K+12.3% | $176K | N/A |
| Total Equity | $3.2M+28.2% | $2.5M-46.8% | $4.7M+44.0% | $3.2M |
| Retained Earnings | -$19.1Mn/m | -$15.4Mn/m | -$11.5M | N/A |
Not reported in any period shown, so not listed: Goodwill.
PCLA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|
| Operating Cash Flow | -$3.7Mn/m | -$1.7Mn/m | -$5.0Mn/m | -$796K |
| Depreciation & Amortization | $179K+24.3% | $144K+77.1% | $81K+43.2% | $57K |
| Stock-Based Compensation | $35K | N/A | N/A | N/A |
| Capital Expenditures | $192K+45.8% | $131K-4.2% | $137K+456.9% | $25K |
| Free Cash Flow | -$3.9Mn/m | -$1.8Mn/m | -$5.1Mn/m | -$821K |
| Investing Cash Flow | -$311Kn/m | -$307Kn/m | -$137Kn/m | -$107K |
| Financing Cash Flow | $4.5M+104.9% | $2.2M-64.4% | $6.2Mn/m | -$46K |
| Dividends Paid | N/A | $21K | N/A | N/A |
Not reported in any period shown, so not listed: Share Buybacks.
PCLA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|
| Operating Margin | -110.4% | -57.0% | -112.3% | -2.4% |
| Net Margin | -115.0% | -61.2% | -113.3% | -0.8% |
| Return on Equity | -133.3%+2.0pp | -135.3%-44.2pp | -91.1%-90.0pp | -1.1% |
| Return on Assets | -57.6%-18.7pp | -38.9%+16.3pp | -55.2% | N/A |
| Current Ratio | 2.130.0x | 2.18-0.6x | 2.76 | N/A |
| Debt-to-Equity | 0.02-0.1x | 0.080.0x | 0.04 | N/A |
| Liabilities-to-Equity | 1.31-1.2x | 2.48+1.8x | 0.65 | N/A |
| Asset Turnover | 0.50-0.1x | 0.64+0.1x | 0.49 | N/A |
| FCF Margin | -105.1% | -33.4% | -135.9% | -17.4% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| PicoCELA Inc. PCLA | FY2025 | $3.7M | -$4.2M | N/A | $56.5M | 50/100 |
| IQSTEL INC. IQST | FY2025 | $316.9M | -$8.5M | -2.7% | $9.7M | 47/100 |
| SurgePays, Inc. SURG | FY2025 | $57.0M | -$36.1M | -63.3% | $7.3M | 18/100 |
| uCloudlink Group Inc. UCL | FY2025 | $81.4M | $6.3M | 7.7% | $8.9M | 54/100 |
| Radcom Ltd. RDCM | FY2025 | $71.5M | $12.0M | 16.8% | $169.1M | 66/100 |
Where PicoCELA Inc. Ranks
Frequently Asked Questions
What is PicoCELA Inc.'s annual revenue?
PicoCELA Inc. (PCLA) reported $3.7M in total revenue for fiscal year 2025. This represents a -32.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is PicoCELA Inc.'s revenue growing?
PicoCELA Inc. (PCLA) revenue declined by 32.8% year-over-year, from $5.5M to $3.7M in fiscal year 2025.
Is PicoCELA Inc. profitable?
No, PicoCELA Inc. (PCLA) reported a net loss of $4.2M in fiscal year 2025.
What is PicoCELA Inc.'s EBITDA?
PicoCELA Inc. (PCLA) had EBITDA of -$3.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does PicoCELA Inc. have?
As of fiscal year 2025, PicoCELA Inc. (PCLA) had $3.6M in cash and equivalents against $71K in long-term debt.
What is PicoCELA Inc.'s return on equity (ROE)?
PicoCELA Inc. (PCLA) has a return on equity of -133.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is PicoCELA Inc.'s free cash flow?
PicoCELA Inc. (PCLA) recorded an outflow of $3.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is PicoCELA Inc.'s operating cash flow?
PicoCELA Inc. (PCLA) recorded an outflow of $3.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are PicoCELA Inc.'s total assets?
PicoCELA Inc. (PCLA) had $7.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are PicoCELA Inc.'s capital expenditures?
PicoCELA Inc. (PCLA) invested $192K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does PicoCELA Inc. spend on research and development?
PicoCELA Inc. (PCLA) invested $177K in research and development during fiscal year 2025.
What is PicoCELA Inc.'s current ratio?
PicoCELA Inc. (PCLA) had a current ratio of 2.13 as of fiscal year 2025, which is generally considered healthy.
What is PicoCELA Inc.'s debt-to-equity ratio?
PicoCELA Inc. (PCLA) had a debt-to-equity ratio of 0.02 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is PicoCELA Inc.'s liabilities-to-equity ratio?
PicoCELA Inc. (PCLA) had a liabilities-to-equity ratio of 1.31 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is PicoCELA Inc.'s return on assets (ROA)?
PicoCELA Inc. (PCLA) had a return on assets of -57.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is PicoCELA Inc.'s P/E ratio?
PicoCELA Inc. (PCLA) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $56.5M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PicoCELA Inc.'s price-to-sales ratio?
PicoCELA Inc. (PCLA) trades at 15.3x sales, its market capitalization divided by $3.7M revenue, FY2025. The market capitalization is $56.5M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does PicoCELA Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, PicoCELA Inc. (PCLA) held $3.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.7M over that year. Dividing the one by the other, the reported balance equals about 12 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is PicoCELA Inc.'s Altman Z-Score?
PicoCELA Inc. (PCLA) has an Altman Z-Score of 3.74, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is PicoCELA Inc.'s Piotroski F-Score?
PicoCELA Inc. (PCLA) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are PicoCELA Inc.'s earnings high quality?
PicoCELA Inc. (PCLA) reported a net loss of $4.2M while operations used $3.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can PicoCELA Inc. cover its interest payments?
PicoCELA Inc. (PCLA) reported an operating loss of $4.1M against $118K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is PicoCELA Inc.?
PicoCELA Inc. (PCLA) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.